Transforming Biotech Field Operations: Enhancing Efficiency and Accuracy with Doc Sonar's Gen AI-Driven Solution.
Learn how a leading biotech improved field operations with Agilisium's Doc Sonar, a Gen AI-driven solution that streamlines information access and enhances efficiency and accuracy for field representatives. Access to the case study - https://bit.ly/4b7UMe2
Learn how a leading biotech improved field operations with Agilisium's Doc Sonar, a Gen AI-driven solution that streamlines information access and enhances efficiency and accuracy for field representatives. Access to the case study - https://bit.ly/4b7UMe2
In the life sciences, forecasting and demand management have never been more difficult, particularly for CROs and CDMOs. Read Automata's latest whitepaper to learn more about the role automation can play in labs ⬇️
Executive Director for Cell Therapies at BMS; PDA Board of Directors; Chair of PDA ATMP Advisory Board, TR56 ATMP Annex and ANS-007
Join me at the next Bioprocess Online Live for a digital discussion of best practices to ensure that the analytical methods you're developing today are seamlessly transferable tomorrow.
Our recent acquisition of Fluent BioSciences is set to transform single-cell research. In our latest article, Cande Rogert and Soroush Zarandi, PhD, MBA discuss how PIPseq V simplifies workflows and brings high-throughput applications to every lab. Dive into the details and see how we’re making cutting-edge technology accessible to all: https://bit.ly/4f8rBcL. And if you’re attending #ASHG24, don’t miss our talk on the power of PIPseq V in scRNA-Seq!
Already a trusted partner to life science innovators, ELIQUENT's expanded platform of due diligence solutions delivers the same valuable insight to companies considering life sciences transactions. Learn more about how ELIQUENT empowers decisions and drives value at https://lnkd.in/e8BDUwrk
🚀 New article alert! 🚀 Curious about the complexities of AAV gene therapy and the critical role of potency assays? Check out our latest article, "Optimizing AAV Potency Assay Development," where Samantha Powers, PhD, Julia Z., and myself explore Forge Biologics' tiered approach to developing robust assays that help bring life-changing gene therapies to market. Learn how regulatory guidelines are evolving, the challenges of potency assay development, and strategies to ensure successful tech transfer between developers and Forge. 🔬 #GeneTherapy #AAV #PotencyAssays #BiotechInnovation #ForgeBiologics #LifeSciences
🧬 3 Tiers for AAV Potency Assay Development Success 🧬 A flexible approach to quantitative potency assay development is essential at every stage. In our latest Endpoints News article, discover how Forge’s stage-agnostic, tiered approach helps meet this critical need. Rachael Hardison, Ph.D., shares how Forge has enhanced transduction efficiency through dose-response experiments and innovative transduction enhancers. The article also includes a step-by-step framework for seamless tech transfer of potency assays from developers to their CDMO partners. Contributing authors: Samantha Powers, PhD, Scientist II, Analytical Development Julia Z., Associate Scientist II, Analytical Development Read more here: https://hubs.li/Q02RxX3M0
Not sure how to get started with ioChem-BD? Follow the user guide we have prepared to make sure you don't miss anything. All the information here --> https://lnkd.in/dKZMYtEG #ioChemCore
Matthew Tong shared this insightful publication that highlights how trial efficiency can transform early-stage biotech. At Intelisci, we provide flexible recruitment solutions that support Phase I studies by helping teams streamline processes and allocate resources effectively, ensuring a smooth progression through development without compromising on quality. #BiotechR&D #ClinicalTrials #TrialEfficiency #DrugDevelopment #Intelisci #Recruitment
Here’s an interesting publication detailing how trial efficiency can reshape early-stage development in #biotech... In Phase I studies, every decision affects the development pathway, making trial design and timing critical. By introducing flexibility into these early phases, clinical teams can meet complex study demands without compromising on speed or quality—a balance essential in today’s fast-paced therapeutic field. With streamlined processes, from recruitment through data collection, biotech R&D professionals can better allocate resources, achieve reliable results, and move confidently toward later stages of development. #BiotechR&D #BioTech #BioPharm #EarlyStageDevelopment #ClinicalTrials #TrialEfficiency #DrugDevelopment
In this Select Science webinar, leading assay designers, developers and a regulatory expert share their tips on how to mitigate the costly pitfalls of assay scale-up. https://hubs.li/Q02z4Dpm0
HOT TAKE: Hi-C: Not just a juicy drink from your childhood, It might be one of the best techniques we have for doing high throughput metagenomics
